6/17/2019 7:40:07 AM
Arbutus Biopharma Appoints William Collier As President And CEO
6/17/2019 7:39:39 AM
Arbutus Appoints William Collier As Next President & CEO; Announces Retirement Of Current President & CEO, Mark Murray
5/7/2019 10:24:05 AM
Wedbush Is Cutting Arbutus Biopharma Corp. (ABUS) FY19 Rev. Estimate To 4.7 M From 6.5 M
5/7/2019 10:23:52 AM
Wedbush Is Cutting Arbutus Biopharma Corp. (ABUS) Q4 19 Rev. Estimate To 1.3 M From 1.7 M
5/7/2019 10:23:43 AM
Wedbush Is Lowering Arbutus Biopharma Corp. (ABUS) Q3 19 Rev. Estimate To 1.4 M From 1.7 M
5/7/2019 10:23:31 AM
Wedbush Is Cutting Arbutus Biopharma Corp. (ABUS) Q2 19 Rev. Estimate To 1.4 M From 1.6 M
5/7/2019 10:13:52 AM
Wedbush Is Lowering Arbutus Biopharma Corp. (ABUS) FY19 Estimate To -1.44 From -1.24
5/7/2019 10:13:40 AM
Wedbush Is Lowering Arbutus Biopharma Corp. (ABUS) Q4 19 Estimate To -0.30 From -0.29
5/7/2019 10:13:10 AM
Wedbush Is Cutting Arbutus Biopharma Corp. (ABUS) Q3 19 Estimate To -0.34 From -0.32
5/7/2019 10:13:00 AM
Wedbush Is Cutting Arbutus Biopharma Corp. (ABUS) Q2 19 Estimate To -0.34 From -0.32
11/26/2018 4:53:32 PM
Arbutus Appoints Frank Torti As Chairman Of Its Board Of Directors
10/15/2018 6:29:05 AM
Wedbush Lifts Arbutus Biopharma Corp. (ABUS) To Neutral From Underperform With $ Price Target
10/9/2018 4:53:34 PM
Wedbush Lowers Arbutus Biopharma Corp. (ABUS) To Underperform From Neutral With $5 Down From $7 Price Target
8/13/2018 8:32:39 AM
Arbutus’ LNP Licensee Alnylam Announces FDA Approval Of ONPATTRO For ATTR Amyloidosis
8/13/2018 7:17:34 AM
Wedbush Is Increasing Arbutus Biopharma Corp. (ABUS) FY18 Rev. Estimate To 3.1 M From 1.4 M
8/13/2018 7:17:17 AM
Wedbush Is Increasing Arbutus Biopharma Corp. (ABUS) FY18 Estimate To -1.09 From -1.40
8/13/2018 7:16:50 AM
Wedbush Is Cutting Arbutus Biopharma Corp. (ABUS) Q4 18 Estimate To -0.37 From -0.34